Viewing Study NCT06093061

Bugs

Ignite Creation Date: 2025-12-17 @ 1:42 PM

Ignite Modification Date: 2025-12-23 @ 4:55 PM

Study NCT ID: NCT06093061

Status:

Last Update Posted:

First Post:

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Contacts Locations Module Design Module Eligibility Module Outcomes Module References Module